DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 3Acino Pharma
03 3Advanz Pharma
04 21Amdipharm Mercury Company Limited
05 12Amdipharm Mercury Debtco Limited
06 3Biological E
07 1Europharmadk Aps
08 3Institut Produits Synthése (Ipsen) Ab
09 6InvaGen Pharmaceuticals Inc
10 42Ipsen
11 16Medartuum
12 35ORIFARM GROUP AS
13 1Omnia L?kemedel Ab
14 5Paranova Pharmaceuticals Ab
15 5Pharmachim Ab
16 6Pharmathen SA
17 6Sun Pharmaceutical Industries Limited
18 3Unimedic AB
19 3Zentiva
01 3Injectable
02 9Injectable Solution In Pre-Filled Syringe
03 1Lanreotide 120Mg 1 Unit Parenteral Use
04 1Lanreotide 30Mg 1 Unit Parenteral Use Rp
05 1Lanreotide 60Mg 1 Unit Parenteral Use
06 1Lanreotide 90Mg 1 Unit Parenteral Use
07 3Long Acting Injectable
08 3PFS
09 1Powder And Solvent For Extended-Release Injectable Suspension
10 1Powder For Injection
11 3Pre Filled Syringe
12 6SOLUTION (EXTENDED RELEASE)
13 9SOLUTION;SUBCUTANEOUS
14 105Solution For Injection
15 3Solution For Injection For Subcutaneous
16 3Solution For Injection In Pre-Filled
17 24Blank
01 3Allowed
02 38Approved
03 9Authorized
04 1Cancelled
05 41Deregistered
06 3EU Approved
07 6Marketed
08 3Originator
09 6PRESCRIPTION
10 18Prescription
11 9RX
12 40Blank
01 3IPSTYL
02 4Ipstyl
03 12Ipstyl Autogel
04 6LANREOTIDE ACETATE
05 3Lanreotid "Amdipharm"
06 3Lanreotid "Pharmathen"
07 3Lanreotida Sun
08 3Lanreotide
09 3Lanreotide Amdipharm
10 3Lanreotide Orifarm
11 3Lanreotide Sun
12 3Lanreotide Zentiva
13 3MYRELEZ
14 3MYTOLAC
15 12Myrelez
16 12Mytolac
17 3SOMATULINE AUTOGEL
18 1SOMATULINE AUTOGEL 120
19 1SOMATULINE AUTOGEL 60
20 1SOMATULINE AUTOGEL 90
21 3SOMATULINE DEPOT
22 1Somatulina
23 16Somatulina Autogel
24 62Somatuline Autogel
25 1Somatuline Autogel 120Mg
26 1Somatuline Autogel 60Mg
27 1Somatuline Autogel 90Mg
28 1Somatuline Pr
29 6Blank
01 24Australia
02 6Canada
03 12Denmark
04 6Estonia
05 3Greece
06 6India
07 10Italy
08 6Norway
09 3South Africa
10 10Spain
11 79Sweden
12 3Switzerland
13 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Lanreotide
Dosage Form : Injectable
Dosage Strength : 60 mg / 0.2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Lanreotide
Dosage Form : Injectable
Dosage Strength : 90 mg / 0.3 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Lanreotide
Dosage Form : Injectable
Dosage Strength : 120 mg / 0.5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Pre Filled Syringe
Dosage Strength : 60MG/0.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Pre Filled Syringe
Dosage Strength : 90MG/0.3ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Pre Filled Syringe
Dosage Strength : 120MG/0.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2021-12-17
Application Number : 215395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LANREOTIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2024-05-21
Application Number : 217193
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SOMATULINE DEPOT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Packaging :
Approval Date : 2007-08-30
Application Number : 22074
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 120Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 120 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 30Mg 1 Unit Parenteral Use Rp
Dosage Strength : 1 bottle IM 30 mg prolonged release + 1 Vial 2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 60Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 60 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ipstyl
Dosage Form : Lanreotide 90Mg 1 Unit Parenteral Use
Dosage Strength : 1 syringe SC 90 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 60MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
